Management of Antipsychotic Treatment Discontinuation and Interruptions Using Model-Based Simulations

Clinical Pharmacology: Advances and Applications - New Zealand
doi 10.2147/cpaa.s32735
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Informa UK Limited

Related search

Does Half-Life Matter After Antipsychotic Discontinuation?

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2017English

The Comparison of Glucose and Lipid Metabolism Parameters in Drug-Naïve, Antipsychotic-Treated, and Antipsychotic Discontinuation Patients With Schizophrenia

Neuropsychiatric Disease and Treatment
2014English

Antipsychotic Potential of CCK-Based Treatments: An Assessment Using the Prepulse Inhibition Model of Psychosis

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
1999English

Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects

Frontiers in Pharmacology
Pharmacology
2019English

Relapse After Antipsychotic Discontinuation in Schizophrenia as a Withdrawal Phenomenon vs Illness Recurrence

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2018English

Pharmacogenetics of Antipsychotic Treatment Response and Side Effects

Therapy
2010English

Osteoporosis Drug Treatment: Duration and Management After Discontinuation. A Position Statement From the SVGO/ASCO

Swiss Medical Weekly
Medicine
2017English

The Influence of Unmeasured Confounding Effects in a Study of Antipsychotic Discontinuation in First-Episode Schizophrenia

American Journal of Psychiatry
PsychiatryMental Health
2018English

Management of Hypnotic Discontinuation in Chronic Insomnia

Sleep Medicine Clinics
Mental HealthNeuropsychologyClinical PsychologyPhysiological PsychologyPsychiatryNeurologyMedicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy